Skip to content Skip to footer

Prohibition Partners Acquires Business of Cannabis

Prohibition Partners Acquires Business of Cannabis
Share this story

Prohibition Holdings Ltd (parent company of Prohibition Partners) today announces its 100% acquisition of Business of Cannabis to form the industry’s new leader in media and data as well as the largest B2B audience in cannabis.

Business of Cannabis, founded in 2017, is a premium media platform that has become one of the definitive news, analysis and data sources for the North American cannabis industry. It is now part of a global portfolio of data, technology and media brands that includes Prohibition Partners, Cannabis Europa, Atalis and BusinessCann. The acquisition will supercharge Business of Cannabis’s ability to offer premium content, experiences and analysis to its North American audience. Business of Cannabis will retain its name and Co-Founder Jay Rosenthal will remain on as Managing Director while also taking on the role of VP, North America for Prohibition Partners.

Stephen Murphy, Co-Founder and CEO of Prohibition Partners, said: “We have long admired the commitment and innovation Blaine, Jay and the team have applied to expertly covering this emerging industry. So we are naturally delighted to be adding Business of Cannabis to our portfolio and in doing so we look forward to providing the North American industry with greater access to best in class data, analysis and events.”

Both the Business of Cannabis and Prohibition Partners teams are presently working on the first cannabis conference in New York since legalisation. ‘Business of Cannabis: New York’ has been designed for industry leaders and will take place at the iconic Rainbow Room in Rockefeller Center on September 29, 2021.

“From our homebase in Toronto, our vision has always been to highlight the companies, brands, people and trends driving the cannabis sector,” said Jay Rosenthal. “By joining Prohibition Partners, we are now uniquely positioned to thrive in new and emerging markets across all of North America, especially markets like New York, Florida and the Midwest.”

Prohibition Partners is renowned for its leadership in emerging markets – including Europe, Asia and LATAM – and following this acquisition, now offers the only true global solution for the cannabis industry while also boasting its largest B2B global audience.

Business of Cannabis will continue its North American expansion over the coming year with Co-Founder Blaine Pearson staying on as an advisor to the company.

About Prohibition Partners

Prohibition Partners unlocks the potential of cannabis through data, analysis and intelligence – providing strategic solutions and consultancy services to an international client base of investors, operators, blue chips and government bodies. It is part of a wider portfolio of B2B brands including Cannabis Europa, Business of Cannabis, BusinessCann and Atalis.

www.prohibitionpartners.com

About Business of Cannabis

Launched in 2017 and headquartered in Toronto, Canada – Business of Cannabis is an award-winning, authoritative source for news and analysis of the cannabis industry. Across live and digital channels – Business of Cannabis highlights the companies, brands, people and trends driving the global cannabis industry.

www.businessofcannabis.com

For all press and media enquiries, please email press@prohibitionpartners.com

Recent posts
June 2, 2022
Austria Sees Record Imports of Medical Cannabis in 2021
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022

Catch up on our newest articles that you might have missed

joss-woodhead-3wFRlwS91yk-unsplash
June 2, 2022
Austria Sees Record Imports of Medical Cannabis in 2021
Austria sees record imports of medical cannabis in 2021 while a case at the Supreme Court challenges prohibition. Austria is...
Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...